ليست عنوان مقالات لاتين Hemoptysis as an unusual manifestation of right atrial myxoma Hepatitis C NS3 helicase unwinds RNA in leaps and bounds

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Hemoptysis as an unusual manifestation of right atrial myxoma

2

Hemoptysis caused by aortobronchial fistula

3

Hemoptysis caused by Hughes-Stovin syndrome

4

Hemoptysis demonstrated on Tc99m-sulfur colloid scanning: A rare complication of amoebic liver abscess

5

Hemoptysis from an unusual pulmonary arteriovenous malformation

6

Hemoptysis From Collateral Arteries 12 Years After a Fontan-Type Operation

7

Hemoptysis resulting from unilateral pulmonary artery agenesis

8

Hemoptysis Secondary to Pulmonary Artery Pseudoaneurysm After Necrotizing Pneumonia

9

Hemoptysis secondary to pulmonary pseudoaneurysm 30 years after a gunshot wound

10

Hemoptysis. A rare presentation of a vallecular cyst

11

Hemopump 31, the sternotomy hemopump: Clinical experience

12

Hemopump treatment in patients with postcardiotomy heart failure

13

Hemorheolocical and photoplethysmographical modifications with aging

14

Hemorheological and cardiovascular effects of exercise training in the rehabilitation of elderly patients with chronic obstructive pulmonary disease

15

Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer’s type: adverse effects on cerebromicrovascular system.

16

Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects

17

Hemorheology by Microchannel Method in Males with Metabolic Syndrome

18

Hemorrhage activates catecholaminergic neurons sensitive to GABA in the nucleus of the solitary tract with ascending projections to the subfornical organ in rats

19

Hemorrhage Activates Myocardial NFκB and Increases TNF-α in the Heart

20

Hemorrhage after pancreaticoduodenectomy: when is surgery still indicated?

21

Hemorrhage and the Use of Blood Products After Adult Cardiac Operations: Myths and Realities

22

Hemorrhage of the optic dik in normal-tenion glaucoma

23

Hemorrhage Treatment Report of Patients Suffering from Glanzmann’s Thrombasthenia Resulting Hospitalization from 2006 to 2011 at Mofid Children’s Hospital

24

Hemorrhages Seen on Brain Images After Mild Traumatic Brain Injury May Increase the Risk of Post-concussion Syndrome

25

Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification

26

Hemorrhagic ascites: an unusual manifestation of prostate carcinoma

27

Hemorrhagic Auricular Schwannoma: A case report

28

Hemorrhagic bowel syndrome in dairy cattle in Iran: a case report

29

Hemorrhagic brain metastases as a manifestation of metastatic malignant melanoma

30

Hemorrhagic cardiac tamponade in critically ill patients with acute renal failure

31

Hemorrhagic cerebral metastases from thyroid cancer on T2*-weighted gradient echo MRI

32

Hemorrhagic Complication from Glaucoma urgery in Patient on Anticoagulation Therapy or Antiplatelet Therapy Original Reearch Article

33

Hemorrhagic complication in an unupected macular choroidal melanoma

34

Hemorrhagic complications after nephron-sparing surgery: Angiographic diagnosis and management by transcatheter embolization: Heye S, Maleux G, Van Poppel H, Oyen R, Wilms G, Department of Radiology, University Hospitals Gasthuisberg, Belgium

35

Hemorrhagic Complications of Intravenous Heparin Use

36

Hemorrhagic Corpus Luteum is Associated with Ovarian Edema

37

Hemorrhagic Corpus Luteum With Generalized Abdominal Pain in Patients With Idiopathic Thrombocytopenic Purpura

38

Hemorrhagic Cystitis Following Cephalexin Overdose in a Child

39

HEMORRHAGIC DISEASE OF THE NEWBORN: CLINICAL PRESENTATION AND RESPONSE TO TREATMENT WITH VITAMIN K

40

Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis

41

Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis

42

Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial)

43

Hemorrhagic Events in Patients Receiving Heparin or Enoxaparin in Combination With Oral Antithrombotics, NSAIDs, and Antiplatelet Medications: A Multi-Center Case-Series Study

44

Hemorrhagic Fever with Acute Renal Failure: A Report from Kosova

45

Hemorrhagic Fever With Renal Syndrome and Its History in Iran

46

Hemorrhagic Gastritis Associated with Renal Failure, Hemoglobinuria, and Isolation of Clostridium perfringens in a Horse

47

Hemorrhagic pericardial effusion leading to cardiac tamponade, as presenting feature of COVID-19 in a young man: a case report

48

Hemorrhagic Posterior Reversible Encephalopathy Syndrome: A Rare Neurological Complication of COVID-19 Infection

49

Hemorrhagic shock from a ruptured ectopic pregnancy in a patient with a negative urine pregnancy test result

50

Hemorrhagic type Moyamoya disease

51

Hemostasis and exercise

52

Hemostasis as an optimal system

53

Hemostasis by means of a cautery knife equipped with an air spray for burns over a large area

54

Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders

55

Hemostasis in newborns of smoking and nonsmoking mothers, ,

56

Hemostasis in Off-Pump Compared to On-Pump Coronary Artery Bypass Grafting: A Prospective, Randomized Study

57

Hemostasis in Oral Surgery

58

Hemostasis in Overt and Subclinical Hyperthyroidism

59

Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies, , , ,

60

Hemostasis in uncontrolled esophageal variceal bleeding by self−expanding metal stents: a systematic review

61

Hemostasis Management in Pediatric Mechanical Circulatory Support

62

Hemostasis of the femoral vasculature: Shouldn’t we have an answer by now?, ,

63

Hemostasis of Tiger Prawn Penaeus monodon Affected by Vibrio harveyi, Extracellular Products, and a Toxic Cysteine Protease

64

Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: Analysis of 6007 published patients, ,

65

Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge

66

Hemostatic Agents

67

Hemostatic agents in orthodontics: A review

68

Hemostatic agents versus sutured bolster during laparoscopic partial nephrectomy

69

Hemostatic capability of rapidly curable glues from gelatin, poly(L-glutamic acid), and carbodiimide

70

Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model

71

Hemostatic effects of aprotinin, tranexamic acid and ε-aminocaproic acid in primary cardiac surgery

72

Hemostatic Efficacy of Ankaferd Blood Stopper in a Swine Bleeding Model

73

Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting

74

Hemostatic factors, atherogenesis and atherosclerosis

75

Hemostatic Molecular Markers Before the Onset of Disseminated Intravascular Coagulation

76

Hemostatic parameters in pulmonary tuberculosis patients after intensive phase treatment

77

Hemostatic responses to maximal exercise in oral contraceptive users

78

Hemostatic risk factors of coronary artery disease in the Chinese

79

Hemostatic Role of TachoSil Surgical Patch in Cardiac Surgery

80

Hemostatic state and atrial fibrillation (The Framingham Offspring Study)

81

Hemostatic Tampon to Reduce Bleeding following Tooth Extraction

82

Hemosuccus pancreaticus as a rare cause of gastrointestinal bleeding: a report of two cases.

83

Hemosuccus Pancreaticus in a Patient with Celiac Trunk Aneurysm

84

Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformation

85

Hemothorax in type I neurofibromatosis

86

Hemotoxicity of carbon nanotubes

87

Hemotropic Mycoplasmas in Stray Cats in Kerman, Iran

88

Hemoxygenase-1 in Cardiovascular Disease

89

Hemozoin Enhances Maturation of Murine Bone Marrow Derived Macrophages and Myeloid Dendritic Cells

90

Hemp diseases and pests. Management and biological control. An advanced treatise J.M. McPartland, R.C. Clarke and D.P. Watson; CABI Publishing Wallingford, Oxon, price £49.95 (US$90), ISBN 0-85199-454-7

91

Hemp fibre reinforced cashew nut shell liquid composites

92

Hemp fibre reinforced cashew nut shell liquid composites

93

Hemp fibre reinforced composites using chelator and enzyme treatments

94

Hemp Fibres as Novel Green Support Material for Immobilization of Acidithiobacillus ferrooxidans

95

Hemp seed cake in organic broiler diets

96

Hemp seed/evening primrose oil affects expression of STAT3, IL-17, and FOXP3+ in experimental autoimmune encephalomyelitis

97

Hemp: A more sustainable annual energy crop for climate and energy policy

98

HEMP-derived activated carbon fibers by chemical activation with phosphoric acid

99

Hempel S. The Medical Detective: John Snow and the Mystery of Cholera [title in USA ‘The Strange case of the Broad Street Pump] Granta Books, 2006, pp304 ISBN 1-862-07842-4 Hardback £18.99

100

Hempelʹs Raven paradox: a positive approach to cluster analysis

101

Hempseed protein derived antioxidative peptides: Purification, identification and protection from hydrogen peroxide-induced apoptosis in PC12 cells

102

Hemşehrilik and Favouritism in the Context of Political and Civil Society Organizations

103

HEMŞİRELERİN İŞ GÜCÜ VERİMLİLİĞİNİ ETKİLEYEN ÖRGÜTSEL FAKTÖRLER KONUSUNDAKİ TUTUMLARININ BELİRLENMESİ

104

HEMŞİRELERİN ÖRGÜTSEL VATANDAŞLIK DÜZEYLERİNİN BELİRLENMESİ

105

HEMT modelling using semi-physical expressions for the equilibrium space-charge parameters of the modulation-doped heterojunction

106

Hen egg white as a feeder protein for lipase immobilization

107

Hen egg white fractionation by ion-exchange chromatography

108

Hen Egg Yolk Prevents Bacterial Adherence: A Novel Function for a Familiar Food

109

Hen’s egg white hypersensitivity among a group of Egyptian atopic children

110

Hen’s eggshell strength under impact loading Original Research Article

111

HEN-1, a Secretory Protein with an LDL Receptor Motif, Regulates Sensory Integration and Learning in Caenorhabditis elegans

112

Henbit (Lamium amplexicaule L.) control and forage legume tolerance to selected postemergence herbicides

113

Hencky’s logarithmic strain and dual stress–strain and strain–stress relations in isotropic finite hyperelasticity

114

Hendra (Equine Morbillivirus)

115

Hendra virus influences meningoencephalitis-based mortality: A comprehensive review

116

Hendra Virus: A Highly Lethal Zoonotic Agent

117

Hendra-like virus responsible for epidemic in Malaysia

118

He-Ne Laser Irradiation Encourages reparative processes After cartilage loss in New Zealand rabbits

119

HeNe+: resolution of an apparent disagreement between experiment and theory

120

Hengill geothermal volcanic complex (Iceland) characterized by integrated geophysical observations

121

Henipavirus susceptibility to environmental variables

122

Henk F. Moed, Wolfgang Glänzel and Ulrich Schmoch, Editors, Handbook of Quantitative Science and Technology Research: The Use of Publication and Patent Statistics in Studies of S&T Systems, Kluwer Academic Publishers (2004) ISBN 1 4020 2702 8 Hardback (al

123

Henk Postma, 1921–2005

124

Henkelʹs strategy for Asia Pacific

125

Henna, An Antimicrobial Herbal Medicine With Less Negative Effect on Spermatogonial Stem Cell Culture

126

Henney nomination moves forward

127

Henneyʹs FDA nomination on “hold”

128

Hennie Van Greuning, International financial reporting standards — A practical guide (2nd edition), The World Bank, Washington (USA) (2005) ISBN 0-8213-5910-X x+297 p, US$30.00.

129

Henoch Schonlein Purpura in children: clinical analysis of 120 cases

130

Henoch–Sch ̈onlein Purpura Associated with Lung Cancer: When Paraneoplastic Manifestations Impede Oncological Management

131

Henoch-Schoenlein Purpura Following Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Case Report

132

Henoch-Schönlein purpura

133

Henoch-Schonlein Purpura Associated with Methicillin-Resistant Staphylococcus aureus Infection

134

Henoch-Schonlein Purpura in A Child Complicated by Fatal Pulmonary Hemorrhage

135

Henoch-Schonlein Purpura in an Elderly Women Presenting with Severe GI Bleeding: A case report

136

Henoch-Schonlein purpura in children

137

Henoch-Schonlein Purpura in Northeast India: Peculiarities in Presentation

138

Henoch-Schönlein purpura with intracerebral hemorrhage

139

Henoch-Schönlein syndrome induced by carbidopa/levodopa

140

Hénon–Heiles potential as a bridge between nontopological solitons of different types

141

HENOSEPILACHNA SEPTIMA DIEKE (COCCINELLIDAE; COLEOPTERA); A NEW RECORD FOR PAKISTAN ALONG WITH NOTES ON ITS TAXONOMY, HOST PLANTS AND DISTRIBUTION

142

HENOSEPILACHNA VIGINTIOCTOPUNCTATA (FAB.) (EPILACHNINAE; COCCINELLIDAE); ITS TAXONOMY, DISTRIBUTION AND HOST PLANTS IN PAKISTAN.

143

Henri Theil, 1924–2000

144

Henri Wallonʹs Theory of Early Child Development: The Role of Emotions

145

Henrian ideality of iron in liquid uranium solvent at high temperatures

146

Henriciʹs transformation and its application to the computation of derivatives of eigensystems

147

Henricus Mattheus Princen

148

Henrik Kacser (1918–1995): an Annotated Bibliography

149

150

Henriksen and Isbell on f-rings

151

Henriksenʼs contributions to residue class rings of analytic and entire functions

152

Henry Adams and the question of posthistoire

153

Henry Arthur Solomon, MD: a conversation with the editor

154

Henry Bowditch and “The Young Stethoscopist”

155

Henry condensations with 4,6-O-benzylidenylated and non-protected d-glucose and l-fucose via DBU-catalysis

156

Henry Darger: Art and Selected Writings: Michael Bonesteel;Rizzoli International Publications, Inc., New York, 2000, 256 pages, 125 color illustrations; hardbound, $85

157

Henry Hobson Richardson and the small public library in America: A study in topology : Breisch, Kenneth A. Cambridge, MA: MIT Press, 1997. 343 pp. $50.00. ISBN: 0-262-2416-0

158

Henry Hugh Higgins and Frederick Price Marrat: the reluctant palaeobotanists and the Ravenhead collection

159

Henry James and the New Woman: A Feminist Reading of The Bostonians

160

Henry kempe memorial lecture—10th International congress on child abuse and neglect : Child abuse and neglect from an indigenous Australianʹs perspective

161

Henry reaction of fluorinated nitro compounds

162

Henry S. Kaplan Distinguished Scientist Award 2003

163

Henry Swan II, MD

164

Henry Swan II, MD

165

Henry Vartan Kehiaian (1929–2009)

166

Henry W. Lane, Martha L. Maznevski, Mark E. Mendenhall and Jeanne McNett, Editors, The Blackwell Handbook of Global Management: A Guide to Managing Complexity, Blackwell Publishers, Malden, MA (2004).

167

Henry, C.J.K. (Ed.) Novel food ingredients for weight control, Woodhead Publishing Ltd., Cambridge, UK, 2007 (xiv + 358 pp., £135.00, ISBN 1-84569-030-4).

168

Henry, C.J.K. (Ed.) Novel food ingredients for weight control, Woodhead Publishing Ltd., Cambridge, UK, 2007 (xiv + 358 pp., £135.00, ISBN 1-84569-030-4).

169

Henry’s constants of butane, isobutane, 1-butene and isobutene in methanol at 255–320 K

170

Henry’s constants of carbon dioxide in methanol at 250–500 K

171

Henry’s constants of methanol in aqueous systems containing salts

172

Henry’s law constant measurements for formaldehyde and benzaldehyde as a function of temperature and water composition

173

Henry’s law constant, octanol–air partition coefficient and supercooled liquid vapor pressure of carbazole as a function of temperature: Application to gas/particle partitioning in the atmosphere

174

Henry’s law constants and isosteric heats of adsorption at zero loading for multi-wall carbon surfaces with different geometries Original Research Article

175

Henry’s law constants and mass transfer coefficients for methyl bromide and 1,3-dichloropropene applied to Florida sandy field soil

176

Henry’s law constants derived from equilibrium static cell measurements for dilute organic–water mixtures

177

Henry’s law constants for hexachlorobenzene, p,p′-DDE and components of technical chlordane and estimates of gas exchange for Lake Ontario

178

Henry’s law constants of methane, nitrogen, oxygen and carbon dioxide in ethanol from 273 to 498 K: Prediction from molecular simulation

179

Henry’s law constants of phenol and mononitrophenols in water and aqueous sulfuric acid Original Research Article

180

Henry–Nef reaction: a practical and versatile chiral pool route to 2-substituted pyrrolidine and piperidine alkaloids

181

Henryʹs constants of gases and volatile organic compounds in aqueous solutions

182

Henryʹs constants of n-alkanols (methanol through n-hexanol) in water at temperatures between 40°C and 90°C

183

Henryʹs constants of propane, propene, trans-2-butene and 1,3-butadiene in methanol at 255–320 K

184

Henryʹs Law and the solubilities of reactant gases in the modelling of PEM fuel cells

185

Henryʹs Law coefficients of chloropicrin and methyl isothiocyanate

186

Henryʹs law constant and related coefficients for aqueous hydrocarbons, CO2 and H2S over a wide range of temperature and pressure

187

Henryʹs law constant measurements for phenol, o-, m-, and p-cresol as a function of temperature

188

Henryʹs law constants and hydrolysis rate constants of 2,2,2-trifluoroethyl acetate and methyl trifluoroacetate

189

Henryʹs law constants for a diverse set of organic chemicals: Experimental determination and comparison of estimation methods

190

Henryʹs law constants for C2–C3 fluorinated alcohols and their wet deposition in the atmosphere

191

Henryʹs law constants for α-, β-, and γ-hexachlorocyclohexanes (HCHs) as a function of temperature and revised estimates of gas exchange in Arctic regions

192

Henryʹs law constants measurements of alachlor and dichlorvos between 283 and 298 K

193

Henryʹs law constants measurements of the nonylphenol isomer 4(3′,5′-dimethyl-3′-heptyl)-phenol, tertiary octylphenol and γ-hexachlorocyclohexane between 278 and 298 K

194

Henryʹs law constants of 1-butene, 2-methylpropene, trans-2-butene, and 1,3-butadiene in methanol at 374–490 K

195

Henryʹs law constants of 2,2,2-trifluoroethyl formate, ethyl trifluoroacetate, and non-fluorinated analogous esters

196

Henryʹs law constants of halogenated organic acids

197

Henryʹs law constants of propane, propene, butane, and 2-methylpropane in methanol at 374–490 K

198

Hens are motivated to dustbathe in peat irrespective of being reared with or without a suitable dustbathing substrate

199

Hens’ welfare to egg quality: a European perspective

200

Hensel′s Lemma and the Divisibility by Primes of Stirling-like Numbers Original Research Article

201

Henselian residually p-adically closed fields

202

Henselian Valued Stable Fields

203

Hensleyʼs problem for complex and non-Archimedean meromorphic functions

204

Henstock type integral in harmonic analysis on zero-dimensional groups

205

Henstock–Kurzweil delta and nabla integrals ✩

206

Henstock–Kurzweil–Pettis integrability of compact valued multifunctions with values in an arbitrary Banach space

207

Henstockʹs multiple wiener integral and henstockʹs version of hu-meyer theorem

208

heoretical studies on shuttle checking: Part II-Shuttle checking by swell P K Hari K N Gupta B K Behera S G Joshi

209

heoretical studies on shuttle checking: Part II-Shuttle checking by swell P K Hari K N Gupta B K Behera S G Joshi

210

heory of Markov systems with fuzzy states

211

Hep atop rotective Potentials of Ghrelin and/or N-Acetyl Cysteine in Thioacetamide Induced Chronic Liver Injury in Rats

212

Hep atop rotective Role for Querectin in Diabetic Rats: Hypolipidemic and Antioxidant Effects

213

HEP computing in Korea Original Research Article

214

HEp-2 cell classification using rotation invariant co-occurrence among local binary patterns

215

HEp-2 cell image classification with multiple linear descriptors

216

HEp-2 cell pattern classification with discriminative dictionary learning

217

HEp-2 cells classification via sparse representation of textural features fused into dissimilarity space

218

HEp-2 fluorescence pattern classification

219

HEp-2 image classification using intensity order pooling based features and bag of words

220

HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases

221

Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks

222

Heparan sulfate abnormalities in exostosis growth plates

223

Heparan sulfate is the main sulfated glycosaminoglycan species in internal organs of the male cockroach, Periplaneta americana

224

Heparan sulfate isomers in cerebral arteries of Japanese women with aging and with atherosclerosis—heparitinase and high-performance liquid chromatography determinations

225

Heparan sulfate proteoglycans. Essential co-factors in receptor-mediated processes with relevance to the biology of the vascular wall Original Research Article

226

Heparan Sulfate: A Complex Polymer Charged with Biological Activity

227

Heparan sulphate proteoglycans in Alzheimerʹs disease and amyloid-related disorders

228

Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation

229

Heparanase expression in human leukemias is restricted to acute myeloid leukemias

230

Heparanase Gene Hypomethylation as a Potential Biomarker for Precision Screening of Bladder Cancer

231

Heparanase promotes bone destruction and invasiveness in prostate cancer

232

Heparanase Regulates Thrombosis in Vascular Injury and Stent-Induced Flow Disturbance

233

Heparanase, heparan sulfate and perlecan distribution along with the vascular penetration during stellate reticulum retraction in the mouse enamel organ

234

Heparan-like molecules induce the repair of skull defects

235

Heparin accelerates liver regeneration following portal branch ligation in normal and cirrhotic rats with increased plasma hepatocyte growth factor levels

236

Heparin Activates PKR by Inducing Dimerization

237

Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood

238

Heparin after percutaneous intervention (HAPI): prospective multicenter randomized trial of three heparin regimens after successful coronary intervention

239

Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure

240

Heparin and aspirin in stroke

241

Heparin and aspirin in stroke

242

Heparin and aspirin in unstable angina: Insufficient sample size may lead to erroneous conclusions

243

Heparin and inflammatory bowel disease

244

Heparin and its derivatives in the treatment of arterial thrombosis: a review

245

Heparin and Low Molecular Weight Heparin Decrease Nitric Oxide Production by Human Polymorphonuclear Cells

246

heparin and platelet function

247

Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung

248

Heparin antiproliferative activity on bovine pulmonary artery smooth muscle cells requires both N-acetylation and N-sulfonation Original Research Article

249

Heparin as adjunctive therapy to coronary thrombolysis in acute myocardial infarction

250

Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction

251

Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro

252

Heparin binding activity of orf virus F1L protein

253

Heparin Binding and Augmentation of C1 Inhibitor Activity

254

Heparin Binds to the Laminin α4 Chain LG4 Domain at a Site Different from that Found for Other Laminins

255

Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass

256

Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass

257

Heparin Causes the Accumulation of Heparan Sulfate in Cultures of Arterial Smooth Muscle Cells

258

Heparin coated Palmaz-Schatz™ stents are highly thrombo-resistant: baboon A-V shunt study

259

Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier

260

Heparin coating dramatically reduces platelet deposition on incompletely deployed Palmaz-Schatz™ in the baboon A-V shunt

261

Heparin coating of bypass systems

262

Heparin coating of poly(ethylene terephthalate) decreases hydrophobicity, monocyte/leukocyte interaction and tissue interaction

263

Heparin coating of the stent graft — effects on platelets, coagulation and complement activation

264

Heparin Coating With Aprotinin Reduces Blood Activation During Coronary Artery Operations

265

Heparin cofactor II (RbHCII) from rock bream (Oplegnathus fasciatus): Molecular characterization, cloning and expression analysis

266

Heparin column analysis of serum type 5 tartrate-resistant acid phosphatase isoforms

267

Heparin conjugated silica nanoparticle synthesis

268

Heparin coupling in inhibition of calcification of vascular bioprostheses

269

Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair

270

Heparin delivery at the site of angioplasty with a nevel drug delivery sleeve

271

Heparin dosing and outcome in acute coronary syndromes: The GUSTO-IIb experience

272

Heparin effect on platelets and fibrinolysis

273

Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity

274

Heparin for acute ischaemic stroke: a never-ending story?

275

Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation

276

Heparin in acute coronary syndromes

277

Heparin in calcification prevention of porcine pericardial bioprostheses

278

Heparin in sepsis treatment

279

Heparin in sepsis treatment – Authorsʹ reply

280

Heparin in the treatment of burns: a review

281

Heparin in unstable angina

282

Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: Effect on haemocompatibility

283

Heparin- induced thrombocytopenia (HIT): a case report of CABG patient

284

Heparin Infusion Prior to Stenting (HIPS) trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia

285

Heparin Initiation Before and After Femoral Arterial Access in Primary Percutaneous Coronary Intervention: Side Effects and Angiographic Success Rates

286

Heparin intercalation into reconstituted collagen I fibrils: Impact on growth kinetics and morphology

287

Heparin interference in whole blood sodium measurements in a pediatric setting

288

Heparin Is More Effective Than Inogatran, a Low-Molecular Weight Thrombin Inhibitor in Suppressing Ischemia and Recurrent Angina in Unstable Coronary Disease

289

Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation

290

Heparin potentiates collateral growth but not growth of intramyocardial endarteries in dogs with repeated coronary occlusion

291

Heparin preserves nitric oxide activity in coronary endothelium during ischemia-reperfusion injury

292

Heparin prophylaxis in bedridden patients

293

Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition

294

Heparin Resistance During and Post-Intravenous Nitroglycerin Infusion

295

Heparin Reverses Anaphylactoid Shock in a Porcine Model

296

Heparin reverses Rhodamine 123 extrusion by multidrug resistant cells

297

Heparin study sparks controversy among cardiologists

298

Heparin therapy for deep vein thrombosis: from hospital to home

299

Heparin therapy in electrical burns: First study and pictures

300

Heparin Thromboprophylaxis for Medical Inpatients

301

Heparin use complicates cardiological procedures

302

Heparin versus aspirin in ischaemic stroke

303

Heparin versus aspirin in ischaemic stroke

304

Heparin versus aspirin in ischaemic stroke

305

Heparin vs aspirin in acute ischaemic stroke

306

Heparin, cell adhesion, and pathogenesis of inflammatory bow el disease

307

Heparin, Enoxaparin, and Mechanical Prophylaxis Utilization Evaluation in DVT Prophylaxis in a Major Teaching Hospital in West of Iran

308

Heparinase-II-Catalyzed Degradation of N-Propionylated Heparin

309

Heparin-binding activity of feline herpesvirus type 1 glycoproteins

310

Heparin-binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells

311

Heparin-bonded circuits decrease myocardial ischemic damage

312

Heparin-Bonded Circuits Decrease Myocardial Ischemic Damage: An Experimental Study

313

Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study

314

Heparin-Bonded Covered Stents Versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions: The Randomized VIASTAR Trial (Viabahn Endoprosthesis With PROPATEN Bioactive Surface [VIA] Versus Bare Nitinol Stent in the Treatment of Long Lesions in Sup

315

Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support

316

Heparin-coated bypass circuits in cardiopulmonary bypass: Improved biocompatibility or not

317

Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations

318

Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting

319

Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting procedures

320

Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial

321

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study

322

Heparin-Coated Equipment Reduces the Risk of Oxygenator Failure

323

Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)

324

Heparin-conjugated scaffolds with pore structure of inverted colloidal crystals for cartilage regeneration

325

Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2

326

Heparin-doped affinity electromembranes for thrombin purification

327

Heparin-folate-retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers

328

Heparin-free hemodialysis in the treatment of hypernatremia in severely burned patients

329

Heparin-functionalized chitosan scaffolds for bone tissue engineering Original Research Article

330

Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications

331

Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents

332

Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM)

333

Heparin-induced aldosterone suppression and hyperkalemia

334

Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis

335

Heparin-Induced Cancer Cell Death Review Article

336

Heparin-induced CVA

337

Heparin-induced hyperkalemia after cardiac surgery

338

Heparin-induced platelet dysfunction and cardiopulmonary bypass

339

Heparin-Induced Thrombocytopeni

340

Heparin-induced thrombocytopenia

341

Heparin-induced thrombocytopenia and cardiac surgery

342

Heparin-induced thrombocytopenia and cardiac surgery

343

Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use

344

Heparin-induced thrombocytopenia and cardiovascular diseases

345

Heparin-induced thrombocytopenia and heart operation: Management with tedelparin

346

Heparin-Induced Thrombocytopenia Associated With Bilateral Adrenal Hemorrhage After Coronary Artery Bypass Surgery

347

Heparin-induced thrombocytopenia in coronary bypass surgery

348

Heparin-Induced Thrombocytopenia in Left Ventricular Assist Device Bridge-to-Transplant Patients

349

Heparin-induced thrombocytopenia in the emergency department

350

Heparin-induced thrombocytopenia is rare in pregnancy

351

Heparin-induced thrombocytopenia with thrombotic sequelae: a review

352

Heparin-induced thrombocytopenia: an overview

353

Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery

354

Heparin-induced thrombocytopenia: clinical manifestations and management strategies

355

Heparinization of gas plasma-modified polystyrene surfaces and the interactions of these surfaces with proteins studied with surface plasmon resonance

356

Heparinized and Saline Solutions in the Maintenance of Arterial and Central Venous Catheters After Cardiac Surgery

357

Heparinized bovine pericardium as a novel cardiovascular bioprosthesis

358

Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance

359

Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane

360

Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5

361

Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition

362

Heparinoid Anticoagulation and Topical Fibrin Sealant in Heparin-Induced Thrombocytopenia

363

Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum

364

Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum

365

Heparin–platelet factor 4 antibodies in patients presenting to the ED with thrombosis

366

Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF

367

Heparin-related thrombosis despite normal platelet counts in vascular surgery

368

Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis

369

Heparins in management of acute coronary syndromes without ST-segment elevation

370

Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts

371

Hepatectomy for liver metastases from breast cancer

372

Hepatectomy using traditional Péan clamp–crushing technique under intermittent Pringle maneuver

373

Hepatic “split lesion” in a fatal electrocution case

374

Hepatic “Stem” Cells: Coming Full Circle

375

Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability

376

Hepatic 5′-AMP-Activated Protein Kinase: Zonal Distribution and Relationship to Acetyl-CoA Carboxylase Activity in Varying Nutritional States

377

Hepatic 7-ethoxyresorufin O-deethylase Activity in eel (Anguilla Anguilla) from The Thames Estuary and Comparisons with other United Kingdom Estuaries

378

Hepatic abscess caused by Brucella US, CT and MRI findings: Case report and review of the literature

379

Hepatic activities of CYP1A and thiamine-dependent enzymes in Baltic salmon (Salmo salar) alevins suffering from the thiamine deficiency M74

380

Hepatic Acyl CoA Oxidase1 Inhibition Modifies Brain Lipids and Electrical Properties of Dentate Gyrus

381

Hepatic adenoma and focal nodular hyperplasia: mr findings with superparamagnetic iron oxide– enhanced mri

382

Hepatic adenomatosis: MRI demonstration with the use of superparamagnetic iron oxide

383

Hepatic allograft abscess with hepatic arterial thrombosis

384

Hepatic Alterations in the Amphibian Sclerophrys regularis as Biomarkers for Habitat Destruction

385

Hepatic alterations in the fish Rhamdia quelen contaminated with Folidol 600®

386

Hepatic Alveolar Echinococcosis

387

Hepatic alveolar echinococcosis: MRI findings

388

Hepatic Alveolar Hydatid Cyst: A Brief Review of Published Cases from Iran in the Last 20 Years

389

Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats

390

Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hypethyroid rats

391

Hepatic amino- to urea-N clearance and forearm amino-N exchange during hypoglycemic and euglycemic hyperinsulinemia in normal man

392

Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease

393

Hepatic and biliary biomarkers in rainbow trout injected with sediment extracts from the River Po (Italy)

394

Hepatic and extrahepatic dehydrogenation/isomerization of 5-cholestene-3β,7α-diol: localization of 3β-hydroxy-Δ5-C27-steroid dehydrogenase in pig tissues and subcellular fractions

395

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

396

Hepatic and Extra-hepatic Transcription of Inter-α-inhibitor Family Genes under Normal or Acute Inflammatory Conditions in Rat

397

Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins

398

Hepatic and Intestinal Schistosomiasis: Review

399

Hepatic and renal concentrations of 10 trace elements in crocodiles (Crocodylus niloticus) in the Kafue and Luangwa rivers in Zambia

400

Hepatic and renal concentrations of vitamins E and C in lead- and ethanol-exposed rats. An assessment of their involvement in the mechanisms of peroxidative damage

401

Hepatic and renal metallothionein induction by an oral equimolar dose of zinc, cadmium or mercury in mice

402

Hepatic and skeletal muscle glycogen metabolism in rats with short-term cholestasis

403

Hepatic and splenic sarcoidosis as a cause of hypercalcemia: a case report

404

Hepatic angiomyolipoma with minimal fat content: MR demonstration

405

Hepatic Angiomyolipoma: a Rarely Described Tumor

406

Hepatic angiomyolipoma: Demonstration by out of phase MRI

407

Hepatic angiomyolipoma: Value of proton (fat/water) chemical shift fast low angle shot (FLASH) MR imaging technique in detecting fatty tissue content

408

HEPATIC ANGIOSARCOMA: REPORT OF A CASE WITHOUT A HISTORY OF EXPOSURE TO ENVIRONMENTAL RISK FACTORS

409

Hepatic antioxidant enzymes and total glutathione of Cyprinus carpio exposed to three disinfectants, chlorine dioxide, sodium hypochlorite and peracetic acid, for superficial water potabilization

410

HEPATIC ANTIOXIDANT, OXIDATIVE STRESS an‎d HISTOPATHOLOGICAL CHANGES INDUCED BY NICOTINE IN A GENDER BASED STUDY IN ADULT RATS

411

Hepatic apolipoprotein and LDL receptor gene expression in the genetically hypercholesterolemic (RICO) rat Original Research Article

412

Hepatic Arterial Blood Flow Index Is Associated with the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection

413

Hepatic arterial blood flow velocities: assessment by transcutaneous and intravascular Doppler sonography

414

Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma

415

Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview

416

Hepatic Arterial Infusion Chemotherapy with Cisplatin for TACE-Refractory or -Ineligible Hepatocellular Carcinoma with Child-Pugh Score of 8 or Above

417

Hepatic arterial infusion for hepatic metastases from Colon Cancer

418

Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi

419

Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi

420

Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure

421

Hepatic Artery and Portal Vein Doppler Indexes in Non‑alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs

422

Hepatic Artery Aneurysms as a Rare but Important Cause of Abdominal Pain; a Case Series

423

Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors

424

Hepatic artery chemotherapy and colorectal liver metastases

425

Hepatic artery chemotherapy and colorectal liver metastases

426

Hepatic artery chemotherapy and colorectal liver metastases

427

Hepatic artery chemotherapy and colorectal liver metastases

428

Hepatic artery embolisation with a novel radiopaque polymer causes extended liver necrosis in pigs due to occlusion of the concomitant portal vein

429

Hepatic artery infusion for liver metastases from colorectal cancer

430

Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation

431

Hepatic artery ligation: a simple and safe technique to treat extrahepatic aneurysms of the hepatic artery

432

Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development

433

Hepatic Artery Pseudoaneurysm ; Simple or Difficult to Diagnose

434

Hepatic artery pseudoaneurysm; a rare complication of Amoebic liver abscess

435

Hepatic Basolateral Plasma High-affinity Ca2+-RATPase is Inhibited by Nitric Oxide and Peroxynitrite Anion

436

Hepatic bile salt flux does not modulate level and activity of the sinusoidal Na+-taurocholate cotransporter (ntcp) in rats

437

Hepatic binding proteins translocating azo dye carcinogen metabolites from cytoplasm into nucleus in rats

438

Hepatic biomarkers of sediment-associated pollution in juvenile turbot, Scophthalmus maximus L.

439

Hepatic biomarkers of xenobiotic metabolism in eighteen marine fish from NW Mediterranean shelf and slope waters in relation to some of their biological and ecological variables

440

Hepatic biotransformation of alkylresorcinols is mediated via cytochrome P450 and β-oxidation: A proof of concept study

441

Hepatic bisegmentectomy 7–8 for a colorectal metastasis

442

Hepatic blood flow and splanchnic oxygen consumption in patients with hepatic encephalopathy before and after high-volume plasmapheresis

443

Hepatic blood flow responses to mechanical stimulation of the skin in anaesthetised rats

444

Hepatic branch vagotomy can block liver regeneration enhanced by ursodesoxycholic acid in 66% hepatectomized rats

445

HEPATIC CAPILLARIASIS IN CHILDREN: REPORT OF 3 CASES IN BRAZIL

446

Hepatic cavernous hemangiomas: Patterns of contrast enhancement on MR fluoroscopy imaging

447

Hepatic cell-specific ATP-binding cassette (ABC) transporter profiling identifies putative novel candidates for lipid homeostasis in mice

448

Hepatic cellular and tissue pathologic response in the mosquito fish, Gambusia affinis, to different time exposure of diethylnitrosamine

449

Hepatic Changes in the Freeze-Tolerant Turtle Chrysemys picta marginata in Response to Freezing and Thawing

450

Hepatic Choristoma: an Unexpected Finding During Cholecystectomy

451

Hepatic clearance of advanced glycation end products (AGEs)—myth or truth?

452

Hepatic CYP1A in winter flounder (Pleuronectes americanus) along the Northeast Coast: Results from the national benthic surveillance project

453

Hepatic CYP1A levels and EROD activity in English sole: biomonitoring of marine contaminants in Vancouver Harbour

454

Hepatic CYP450 gene expression, hematological and biochemical indices in Caspian roach (Rutilus caspius) induced by Endosulfan

455

Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia

456

Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase

457

Hepatic cytochrome P4501A and 7-ethoxyresorufin O-deethylase induction in mullet and common sole as an indicator of toxic organic pollution in Izmir Bay, Turkey

458

Hepatic differentiation of porcine induced pluripotent stem cells in vitro

459

Hepatic DNA adducts and production of mutagenic urine in 2,6-dinitrotoluene-treated B6C3F, male mice

460

Hepatic duct diverticulum

461

Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation

462

Hepatic dysfunction associated with atenolol

463

Hepatic Dysfunction in Ambulatory Patients With Heart Failure: Application of the MELD Scoring System for Outcome Prediction

464

Hepatic dysfunction in critically ill patients

465

Hepatic Effects of Endothelin: Metabolism of [125I]Endothelin-1 by Liver-Derived Cells

466

Hepatic elemental contents and antioxidant enzyme activities in Algerian mice (Mus spretus) inhabiting a mine area in central Portugal

467

Hepatic encephalopathy and ascites

468

Hepatic encephalopathy and ascites

469

Hepatic encephalopathy and nitric oxide

470

Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?

471

Hepatic Encephalopathy Linked to COVID-19 in a Pediatric Case: A Rare Presentation of COVID-19

472

Hepatic encephalopathy: Clinical aspects and pathogenetic concept

473

Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis

474

Hepatic Energy and Substrate Metabolism: A Possible Metabolic Basis for Early Nutritional Support in Cirrhotic Patients

475

Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response

476

Hepatic Epithelioid Hemangioendothelioma: A Review of Three Liver Transplant Recipients

477

Hepatic EROD Activity in Flounder (Platichthys flesus) as an Indicator of Contaminant Exposure in English Estuaries

478

Hepatic ethoxyresorufin O-deethylase (EROD) activity in flounder (Platichthys flesus) from contaminant impacted estuaries of the United Kingdom: continued monitoring 1999–2001

479

Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases

480

Hepatic expression of regeneration marker genes following partial hepatectomy in the rat : Influence of 1,25-dihydroxyvitamin D3 in hypocalcemia

481

Hepatic expression profiling in smolting and adult coho salmon (Onchorhynchus kisutch)

482

Hepatic Failure After Bariatric Surgery: A Systematic Review

483

Hepatic Failure in a Young Woman Following Ingestion of Tribulus Terrestris

484

Hepatic Failure Related to Itraconazole Use Successfully Treated by Corticosteroids

485

Hepatic fatty acid metabolism in rats fed diets with different contents of C18 : 0, C18 : 1 cis and C18 : 1 trans isomers

486

Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids

487

Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways

488

Hepatic fructose-metabolizing enzymes and related metabolites: role of dietary copper and gender

489

Hepatic functional reserve in patients with obstructive jaundice: An assessment by the redox tolerance test

490

Hepatic gene expression and lipid parameters in complement C3−/− mice that do not develop ethanol-induced steatosis

491

Hepatic gene expression and plasma albumin concentration related to outcome after attenuation of a congenital portosystemic shunt in dogs

492

Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients

493

Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice

494

Hepatic gene expression profile in brown trout (Salmo trutta) exposed to traffic related contaminants Original Research Article

495

Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes

496

Hepatic gene induction in murine bone marrow after hepatectomy

497

Hepatic glucose metabolism in humans—its role in health and disease

498

Hepatic glucose output response to nicotine and the underlying neural mechanism in rats

499

Hepatic Glutamate Dehydrogenase Activity and the Presence of Ammonia and Urea in the Circulatory Fluid of Channa Gachua in WaterRestricted Condition

500

Hepatic glutaminase—a special role in urea synthesis?

501

Hepatic glutamine metabolism

502

Hepatic glutamine metabolism during endotoxemia in neonatal rats

503

Hepatic glutathione in English sole (Pleuronectes vetulus): Response to complex mixtures of xenobiotics

504

Hepatic glutathione S-transferase activity in flounder collected from contaminated and reference sites along the Polish coast

505

Hepatic glutathione S-transferases from lamprey (Petromyzom marinus): purification and characterization

506

Hepatic granuloma mimicking recurrent lymphoma on ^18F-FDG PET/CT in a patient with primary mediastinal diffuse large B-cell lymphoma

507

Hepatic granulomas associated with brucellosis

508

Hepatic Health and Humoral Immunological Parameters of Common Carp (Cyprinus carpio) Fed Lactic Acid-supplemented Diets

509

Hepatic hemosiderosis in buffalo fish (Ictiobus spp.)

510

Hepatic histology in obese patients undergoing bariatric surgery

511

Hepatic histopathology in two populations of the mummichog, Fundulus heteroclitus

512

Hepatic hyaline globules in an Eclectus parrot (Eclectus roratus)

513

Hepatic hydatid cyst presenting as a cutaneous fistula

514

HEPATIC HYDROTHORAX WITH MODERATE ASCITIS IN A NIGERIAN

515

Hepatic hydrothorax: pathogenesis, diagnosis, and management

516

Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), ,

517

Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection

518

Hepatic Impact of Different Concentrations of Hibiscus rosa Zinc Oxide Nanoparticles on Rats

519

Hepatic inflammatory mass secondary to toothpick perforation of the stomach: triphasic CT appearances

520

Hepatic injury and vitamin A ingestion

521

Hepatic Involvement and Association with Prognosis in COVID-19 Patients: A Single-Centre Report from Iran

522

Hepatic Involvement in Dengue Fever in Children

523

Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C

524

Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del “loss of function” mutations in ferroportin disease

525

Hepatic iron metabolism gene expression profiles in HFE associated Hereditary Hemochromatosis

526

Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study.

527

Hepatic iron overload and hepatocellular carcinoma

528

Hepatic iron overload in alcoholic liver disease: why does it occur and what is its role in pathogenesis?

529

Hepatic iron status and response to therapy in chronic viral hepatitis B and C: A preliminary report

530

Hepatic Ischemia and Reperfusion Injury and Trauma: Current Concepts

531

Hepatic ischemia secondary to hepatic artery ligation: MRI findings

532

Hepatic Ischemia/Reperfusion Injury Is Diminished by Atorvastatin in Wistar Rats

533

Hepatic ischemia-reperfusion injury

534

Hepatic ischemia-reperfusion injury

535

Hepatic levels of metal and metallothioneins in two commercial fish species of the Northern Iberian shelf

536

Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture Original Research Article

537

Hepatic lipase mediates lipoprotein uptake into cells via LDL receptor-related protein

538

Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: The Copenhagen City Heart Study

539

Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor

540

Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study

541

Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice

542

Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model

543

Hepatic lipidosis in a common Mynah (Acridotheres tristis) associated with pododermatitis and consumption of broiler pelleted feed

544

Hepatic lipogenic enzyme expression in pigs is affected by selection for decreased backfat thickness at constant intramuscular fat content

545

Hepatic Lobectomy-Case Report of Two Patients, Performed at Chittagong Medical College Hospital

546

Hepatic localisation of rat cysteine dioxygenase

547

Hepatic mesenchymal hamartoma with translocation involving chromosome band 19q13.4: a recurrent abnormality

548

Hepatic metabolism of sulfur amino acids in db/db mice

549

Hepatic metabolism, phase I and II biotransformation enzymes in Atlantic salmon (Salmo Salar, L) during a 12 week feeding period with graded levels of the synthetic antioxidant, ethoxyquin

550

Hepatic metallothionein as a biomarker for metal contamination: age effects and seasonal variation in European flounders (Pleuronectes flesus) from the Severn Estuary and Bristol Channel

551

Hepatic metallothionein concentrations in the golden grey mullet (Liza aurata) – Relationship with environmental metal concentrations in a metal-contaminated coastal system in Portugal

552

Hepatic metastasis complicated by abscess formation

553

Hepatic Microcirculatory Changes Induced by Hepatic Artery Embolization in Rats Original Investigation

554

Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats

555

Hepatic mitochondrial transport of glutathione: Studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells

556

Hepatic mono-oxygenase induction in benthic flatfish sampled near coastal pulp mills in British Columbia

557

Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C

558

Hepatic multi-nodular focal fatty metamorphosis in acquired porphyria cutanea tarda: Sonographic, CT, and mri features

559

Hepatic mycotic aneurysms

560

Hepatic myelopathy Case report with review of the literature

561

Hepatic myelopathy with spastic paraparesis

562

Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase

563

Hepatic Necrosis: A Main Presentation of Systemic Lupus Erythematosus in a Previously Healthy Woman

564

Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease

565

Hepatic Osteodystrophy: a relationship between osteoporotic bone and chronic liver disease

566

Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man

567

Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo

568

Hepatic overlap syndromes

569

Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage

570

Hepatic Oxidative Damages and Glucose Tolerance in Diabetic Rats Exposed to Repeated Oral Doses of Diazinon

571

Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients

572

Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis

573

Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis chronic hepatitis

574

Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy

575

Hepatic portal venous gas

576

Hepatic portal venous gas: clinical significance of computed tomography findings

577

Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects

578

Hepatic protection by perioperative metabolic support?

579

Hepatic protein synthesis rate of liver specimens as a predictor of viability in rat cold ischemia liver transplantation model

580

Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients

581

Hepatic pseudocapillarisation and atherosclerosis in ageing

582

Hepatic radiofrequency ablation using perfusion electrodes in a pig model: Effect of the Pringle manoeuvre

583

Hepatic reduction of insulin-like growth factor (IGF)-I and IGF binding protein-3 that results from fasting is not attenuated in genetically obese rats

584

Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice

585

Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients, , , ,

586

Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat

587

Hepatic resection for hepatocellular carcinoma

588

Hepatic resection for hepatocellular carcinoma in Taiwan

589

Hepatic resection for large hepatocellular carcinoma

590

Hepatic resection for malignant melanoma

591

Hepatic resection for metastatic neuroendocrine carcinomas

592

Hepatic resection for recurrent metastatic ovarian cancer

593

Hepatic resection in breast cancer metastases: should it be considered standard treatment?

594

Hepatic resection in metastatic breast cancer: results and prognostic factors

595

Hepatic resection using stapling devices

596

Hepatic resection with vascular isolation and routine supraceliac aortic clamping

597

Hepatic retractor in an ex vivo model

598

Hepatic Rupture After Heimlich Maneuver

599

Hepatic Sarcodosis presenting as portal hypertension in a young boy

600

Hepatic sarcoidosis: MR appearances in patients with chronic liver disease

601

Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article

602

Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats

603

Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids

604

Hepatic Steatosis

605

Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway

606

Hepatic Steatosis among Obese Children and Adolescents

607

Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening

608

Hepatic steatosis and insulin resistance: Does etiology make a difference?

609

Hepatic Steatosis and Related Factors in Obese Children Attending National Nutritional Institute

610

Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E

611

Hepatic steatosis in chronic hepatitis B and C: Predictors, distribution and effect on fibrosis

612

Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study

613

Hepatic Steatosis in Iranian Patients with Chronic Hepatitis C

614

Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men

615

Hepatic steatosis: An experimental model for quantification

616

Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte

617

Hepatic stellate cell activation in genetic haemochromatosis : Lobular distribution, effect of increasing hepatic iron and response to phlebotomy

618

Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis

619

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis

620

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

621

Hepatic stellate cells (Ito-cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat

622

Hepatic stellate cells and the regulation of liver inflammation

623

Hepatic stellate cells are an important cellular site for β-carotene conversion to retinoid

624

Hepatic stellate cells become susceptible to fas-ligand induced apoptosis during transformation to myofibroblasts

625

Hepatic stellate cells do not derive from the neural crest

626

Hepatic stellate cells in human schistosomiasis mansoni: A comparative immunohistochemical study with liver cirrhosis

627

HEPATIC STELLATE CELLS IN THE CONTEXT OF LIVER FIBROSIS

628

Hepatic stem cells

629

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

630

Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model

631

Hepatic tissue damage induced in Meriones ungliculatus due to infection with Babesia divergens-infected erythrocytes

632

Hepatic Tissue Engineering Using Scaffolds: State of the Art

633

Hepatic Toxocariasis in a Child: ACase Report from Shiraz, Southern Iran

634

Hepatic triacylglycerols and serum non-esterified fatty acids (NEFA) variations in indigenous water buffalo (Bubalus bubalis) in the province of Khuzestan, Iran

635

Hepatic tumor necrosis factors production and distant organ dysfunction in a murine model of obstructive jaundice

636

Hepatic tumours in childhood: An experience at the Children Hospital and Institute of Child Health, Lahore

637

Hepatic undifferentiated embryonal sarcoma: malignant evolution of mesenchymal hamartoma? Study of one case with immunohistochemical and flow cytometric emphasis

638

Hepatic vagotomy inhibits proliferation of hepatic stellate cells in rats with acute hepatitis

639

Hepatic vascular calcification: An early second trimester sonographic feature of idiopathic infantile arterial calcinosis

640

Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family

641

Hepatic vein to the azygous vein anastomosis for pulmonary arteriovenous fistulae

642

Hepatic vein velocities in children with right ventricular hypertension

643

Hepatic vein waveform in liver cirrhosis: Correlation with Child’s class and size of varices

644

Hepatic veno-occlusive disease with immunodeficiency (VODI): First reported case in the U.S. and identification of a unique mutation in Sp110

645

Hepatic Venous Malformation After Modified Fontan Procedure With Partial Hepatic Vein Exclusion

646

Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy

647

Hepatic viral infections in Yemen between 2000-2005

648

Hepatic von Meyenburg complex simulating biliary cystadenocarcinoma

649

Hepatic, Renal and Cardiovascular Biomarker Variability in Type 2 Diabetes Mellitus Patients with Poor Glycemic Control

650

Hepaticocholecystoduodenostomy compared with Roux-en-y choledochojejunostomy for decompression of the biliary tract

651

Hepatiti C and Ocular urface Dieae Original Reearch Article

652

Hepatitis A 2004 Vaccination in Children: Methods and Findings of a Survey in Two States Original Research Article

653

Hepatitis A and B immunization in persons being evaluated for sexually transmitted diseases

654

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

655

Hepatitis A and E: not to be forgotten

656

Hepatitis A and vigorous physical activity

657

Hepatitis A booster vaccination: is there a need?

658

Hepatitis A Chronic Immunity in Iran: A Geographic Information System-Based Study

659

Hepatitis A Chronic Immunity: A Population-Based Seroprevalence Study in Fars Province, Southern Iran

660

Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography

661

HEPATITIS A IN LATIN AMERICA: A CHANGING EPIDEMIOLOGIC PATTERN

662

Hepatitis A in the Eastern Mediterranean Region: A Review on the Prevalence

663

Hepatitis A Infection Presented with Pancytopenia, a Case Series in Children

664

Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report

665

Hepatitis A linked to clotting factors in USA

666

Hepatitis A Prevention Strategies, Haiti Case: Should Rescuers Be Immunized

667

Hepatitis A Seropositivity among First-Year Students of the Medical University in Isfahan, Iran

668

Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study

669

Hepatitis a seroprevalence among young adults: Effects of ACIP immunization recommendations

670

Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran

671

Hepatitis A Vaccination among Thai Medical Students: A Questionnaire Study

672

Hepatitis A vaccine failure

673

Hepatitis A vaccine for Israeli children

674

Hepatitis A vaccine for secondary hepatitis A infection

675

Hepatitis A vaccine for secondary hepatitis A infection

676

Hepatitis A vaccine for secondary hepatitis A infection

677

Hepatitis A vaccine for secondary hepatitis A infection

678

Hepatitis A vaccine for secondary hepatitis A infection

679

Hepatitis A vaccine in the last-minute traveler

680

Hepatitis A virus – a general overview

681

Hepatitis A Virus and Coronary Artery Diseases

682

Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran

683

Hepatitis A virus in environmental water samples from the Amazon Basin

684

Hepatitis A Virus Infection

685

Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV

686

Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers

687

Hepatitis A virus infection: Is it an important hazard to public health?

688

Hepatitis A Virus Seropositivity in Nurses and Paramedical Personnel at a University Hospital in North Iran

689

Hepatitis A virus vaccination in Iranian soldiers needs more attention

690

Hepatitis A Virus: Is Vaccination Necessary in Middle East?

691

Hepatitis A Virus: Seroepidemiological Study in Fars Province

692

Hepatitis A with Pleural Effusion, Ascites and Acalculous Cholecystitis

693

Hepatitis after intravenous buprenorphine misuse in heroin addicts

694

Hepatitis agent cloned and designated hepatitis G virus

695

Hepatitis and community: The current scenario and a roadmap for 2030

696

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

697

Hepatitis and HIV screening, education, and treatment for adults with serious mental illness

698

Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections

699

Hepatitis B among homeless and other impoverished US military veterans in residential care in Los Angeles

700

Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors

701

Hepatitis B and C among thalassemiac patients in Iran: A multicenter study

702

Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors

703

Hepatitis B and C and the Role of Non-specialists on Disease Elimination

704

Hepatitis B and C in HIV-infected patients : Prevalence and prognostic value

705

Hepatitis B and C infection in first-time blood donors in Karachi – a possible subgroup for sentinel surveillance

706

Hepatitis B and C Infections Among Pediatric Patients with Sickle Cell Disease at a Tertiary Hospital in Nigeria

707

Hepatitis B and C Infections and Different Genotypes of HCV Among Sickle Cell Anemia Patients in Ahvaz, South-Western Iran

708

Hepatitis B and C Infections in Hamadan Province during 2004-2009

709

Hepatitis B and C knowledge among Saudi dental patients

710

Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governorate, Egypt

711

Hepatitis B and C Viral Infection: Prevalence, Knowledge, Attitude, Practice, and Occupational Exposure among Healthcare Workers of Jimma University Medical Center, Southwest Ethiopia

712

Hepatitis B and C viral infections in chronic liver disease: a populationbased study in Qatar

713

Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges

714

Hepatitis B and C virus infection and the risk of atherosclerosis in a general population

715

Hepatitis B and C: An alarming situation in Southern part of Khyber Pakhtunkhwa, Pakistan

716

Hepatitis B and C: Prevention is better than cure

717

Hepatitis B and health-care workers

718

Hepatitis B and health-care workers

719

Hepatitis B and health-care workers

720

Hepatitis B and health-care workers

721

Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran

722

Hepatitis B and Hepatitis C Seroprevalence in the Center of Sanliurfa Province From Southeastern Anatolia Region and Related Risk Factors

723

Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: A survey by serologic and molecular methods

724

Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences

725

Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda

726

Hepatitis B and its Relationship With Oxidative Stress

727

Hepatitis B associated liver failure following bone marrow transplantation

728

Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia

729

Hepatitis B Birth Dose among Children in District 2 Hospital, Ho Chi Minh City, Vietnam: Prevalence and Associated Factors

730

Hepatitis B booster vaccination for healthcare workers

731

Hepatitis B Core Antibody ImmunoglobulinMin Blood Donors With a History of Hepatitis B Virus Infection

732

HEPATITIS B e ANTIGEN AND THE RISK OF HEPATOCELLULAR CARCINOMA

733

Hepatitis B e Antigen-Negative Chronic Hepatitis B

734

Hepatitis B envelope protein mutants

735

Hepatitis B epidemiology and cultural practices in Amerindian populations of Amazonia: The Tupí-Mondé and the Xavánte from Brazil

736

Hepatitis B genotypes and the response to interferon therapy

737

Hepatitis B Genotypes in Iran

738

Hepatitis B genotypes in patients with acute hepatitis B virus infection

739

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update

740

Hepatitis B immunisation in chronically transfused recipients

741

Hepatitis B immunisation in Singapore

742

Hepatitis B Immunization in Health Care Workers: Needs and Opportunities

743

Hepatitis B immunization in postpartum women

744

Hepatitis B in a high prevalence New Zealand population: A mathematical model applied to infection control policy

745

Hepatitis B in China

746

Hepatitis B infection among Asian American Pacific Islanders in the Rocky Mountain area

747

Hepatitis B Infection among Korean Americans in Colorado: Evidence of the Need for Serologic Testing and Vaccination

748

Hepatitis B infection among Nigerian children admitted to a children’s emergency room

749

Hepatitis B Infection among Patients Receiving Chronic Hemodialysis at the Royal Medical Services in Jordan

750

Hepatitis B Infection during Renal Replacement Therapy

751

Hepatitis B infection in Eastern Indian families: Need for screening of adult siblings and mothers of adult index cases

752

Hepatitis B infection in Eastern Mediterranean Region: challenges and the way forward

753

Hepatitis B Infection in Hemodialysis Patients in Tehran Province, Iran

754

Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey

755

Hepatitis B infection: Pathogenesis and management

756

Hepatitis B Infection: Prevalence and Response to Vaccination among Health Care Workers in Babol, Northern Iran

757

Hepatitis B is a Serious Health Problem in Some Parts of Iran; Sistan and Baluchestan Province

758

Hepatitis B Knowledge Among Healthy Volunteers in Duhok City, Kurdistan Region, Iraq

759

Hepatitis B Knowledge Among Iranian Adolescents: A National Survey

760

Hepatitis B or hepatitis C and human immunodeficiency virus infection

761

Hepatitis B pregenomic RNA splicing—The products, the regulatory mechanisms and its biological significance

762

Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure

763

Hepatitis B Prevention Education and Afghan Immigrant Students

764

Hepatitis B reactivation after lamivudine

765

Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review

766

Hepatitis B Recurrence After Liver Transplantation: A Single Center Experiences and Review the Literature

767

Hepatitis B resistance in Iran

768

Hepatitis B Seroconversion Rate After Primary Immunization Series with Newly Introduced Pentavalent Vaccine: A Report of Local Study in Alborz Province, Iran, 2016

769

Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand

770

Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013

771

Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014

772

Hepatitis B Splice-Generated Protein Antibodies in Syrian Chronic Hepatitis B Patients: Incidence and Significance

773

Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago

774

Hepatitis B surface antibody purification with hepatitis B surface antibody imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-l-tyrosine methyl ester) particles

775

Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine

776

Hepatitis B Surface Antigen and Viral DNA Detection and Prevalence in Nigeria

777

Hepatitis B surface antigen carrier rate in unvaccinated and vaccinated children with thalassaemia major at Bahawal Victoria Hospital, Bahawalpur, Pakistan

778

HEPATITIS B SURFACE ANTIGEN DISAPPEARANCE AND HEPATITIS B SURFACE ANTIGEN SUBTYPE: A PROSPECTIVE, LONG-TERM, FOLLOW-UP STUDY OF JAPANESE RESIDENTS OF OKINAWA, JAPAN WITH CHRONIC HEPATITIS B VIRUS INFECTION

779

Hepatitis B Surface Antigen Prevalence among Pregnant Women in Rafsanjan City, Iran, 2003

780

Hepatitis B surface antigen prevalence in pregnant women: A cross‑sectional survey in Iran

781

Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria

782

Hepatitis B Surface Antigen, Hepatitis C Virus Antibody, Body Mass Index, and Alcohol Drinking among Workers with Elevated Serum Alanine Aminotransferase

783

Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria

784

Hepatitis B surface antigen-negative, but HBV DNA-positive patients in Bangladesh

785

Hepatitis B testing among Vietnamese American men

786

Hepatitis B transmission from contaminated cryopreservation tank

787

Hepatitis B vaccination after liver transplantation as a strategy to discontinue prophylaxis with hepatitis B immune globulin

788

Hepatitis B vaccination among primary health care workers in Northwest Pakistan

789

HEPATITIS B VACCINATION AND INFANTILE IDIOPATHIC THROMBOCYTOPENIC PURPURA

790

Hepatitis B vaccination coverage among Iranian children aged 15–26 months in 2006

791

Hepatitis B Vaccination Coverage Among Iranian Medical Students and Nursing Staff

792

Hepatitis B Vaccination Coverage and Its Associated Factors in Nurses of Imam Reza (AS) Hospital in Kermanshah

793

Hepatitis B Vaccination Coverage and Sharp Injuries Among Healthcare Workers in Hamadan, Iran

794

Hepatitis B vaccination coverage in medical students at a medical college of Mirpurkhas

795

Hepatitis B Vaccination Coverage, HBS-Ab Level and its Related Factors among Dentistry and Medical Students

796

Hepatitis B Vaccination Efficacy in Iranian Healthcare Workers: A Meta-Analysis Study

797

Hepatitis B vaccination follow-up

798

Hepatitis B Vaccination in Bangladesh: a Suggestion Based on Current Evidence

799

Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients

800

Hepatitis B vaccination in correctional health care workers

801

Hepatitis B vaccination in correctional health care workers

802

Hepatitis B vaccination of babies in Melanesia

803

Hepatitis B vaccination of health care workers in Saudi Arabia

804

Hepatitis B vaccination program at a New York City hospital: Seroprevalence, seroconversion, and declination, ,

805

Hepatitis B Vaccination Reliability in Celiac Disease

806

Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact

807

Hepatitis B vaccination strategy for newborn babies

808

Hepatitis B Vaccination: Needs a Revision

809

Hepatitis B vaccination: to boost or not to boost?

810

Hepatitis B Vaccine Acceptability among Nurses: A Theory Based Conceptualization

811

Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy

812

Hepatitis B vaccine booster dose: Low-dose recombinant hepatitis B vaccines as a booster dose,

813

Hepatitis B vaccine boosting among young healthy adults

814

Hepatitis B vaccine boosting: the debate continues

815

Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana’a, Yemen

816

Hepatitis B vaccine in patients on haemodialysis

817

Hepatitis B vaccine, hepatitis C virus infection, and haemodialysis

818

Hepatitis B Vaccine: Immunity, Efficacy and Types.

819

Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors

820

Hepatitis B viral genotypes and lamivudine resistance

821

Hepatitis B Viral Markers in Surface Antigen Negative Blood Donors: The Need to Look Beyond Antibody Negativity

822

Hepatitis B viral resistance: mechanisms and diagnosis

823

Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling

824

Hepatitis B Virus (HBV) and Occult Hepatitis B Virus (OBI) in Hemodialysis Patients: An Epidemiological Observational Study in Kerman, Iran (2022-2023)

825

Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics

826

Hepatitis B Virus (HBV) Infection among Pregnant Women in Makurdi, Nigeria

827

Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China

828

Hepatitis B Virus / Human Immunodeficiency Virus Co-Infection and Its Hepatocarcinogenic Potential in Sub-Saharan Black Africans

829

Hepatitis B virus among maintainence haemodialysis patients: A report from Karachi, Pakistan

830

Hepatitis B virus among schoolchildren in an endemic area in Egypt over a decade: Impact of hepatitis B vaccine

831

Hepatitis B virus and celiac disease

832

Hepatitis B Virus and Cytomegalovirus Infections Disrupt Sperm Parameters in Males through Decreasing Mitochondrial Membrane Potential: A Case-control Study

833

Hepatitis B virus and hepatocellular carcinoma

834

Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda

835

Hepatitis B virus and host factors

836

Hepatitis B Virus and Malaria Co-infection Causing Significant Changes in Hematological and Liver Function Indices in a Cohort of Subjects in Ilorin, Nigeria

837

Hepatitis B Virus Antibody Levels in High-Risk Health Care Workers

838

Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor

839

Hepatitis B Virus Complications of Pregnancy After Kidney Transplantation

840

Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania

841

Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C

842

Hepatitis B Virus DNA is Absent in Lebanese Blood Donors Who Are Positive for Both Anti-Hbc and Anti-Hbs Antibodies

843

Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran

844

Hepatitis B virus DNA level as predictor of response to therapy with interferon-alpha-2b (PDferon) in chronic hepatitis B infection

845

Hepatitis B virus E antigen but not HBV core is presented to specific CD4+ T cells via the endogenous antigen processing pathway

846

Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro

847

Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors

848

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression

849

Hepatitis B virus genetic diversity in Latin America

850

Hepatitis B virus genetic variability and evolution

851

Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma

852

Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection

853

Hepatitis B Virus Genotype G Infection in a Turkish Patient Undergoing Hemodialysis Therapy

854

Hepatitis B virus genotypes and extrahepatic manifestations

855

Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014

856

Hepatitis B Virus Genotypes in Eastern Azerbaijan, Northwest Iran

857

Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region

858

Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy

859

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

860

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

861

Hepatitis B virus Genotyping Among Patients With Cirrhosis

862

Hepatitis B Virus Immunity Status and Booster Dose Efficacy in Health Sciences Students: An Interventional Study

863

Hepatitis B virus in cervicovaginal lavage samples of pregnant women in Gorgan city, north of Iran

864

Hepatitis B virus induced hepatocellular carcinoma

865

Hepatitis B Virus Infection among Health Colleges’ Students in Aseer Region, Southwestern Saudi Arabia

866

Hepatitis B virus infection among staff in three hospitals in Khartoum, Sudan, 2006–07

867

Hepatitis B Virus Infection and Exposure Among Foreign-Born Asian Americans in the U.S.

868

Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran

869

Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran

870

Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma

871

Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention

872

Hepatitis B Virus Infection Flare Induced Acute-on-chronic Liver Failure After COVID-19 Vaccination: A Case Report

873

HEPATITIS B VIRUS INFECTION IN AN ANTI-HBC NEGATIVE PATIENT: A CASE REPORT

874

Hepatitis B virus infection in Iran

875

Hepatitis B Virus Infection in Iran: A Systematic Review

876

Hepatitis B Virus Infection in Iran: Current Knowledge, Future Plans

877

Hepatitis B Virus Infection in Iranian Hemodialysis Patients A Systematic Review and Meta-Analysis

878

Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers

879

Hepatitis B Virus Infection in Patients with Blood Disorders: A Concise Review in Pediatric S

880

Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis

881

Hepatitis B Virus Infection in Vaccinated Children and Adolescents with HBsAg-positive Parents: Is Routine Vaccination Sufficient?

882

Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran

883

Hepatitis B virus infection without immunological markers after open-heart surgery

884

Hepatitis B virus infection: Current status

885

Hepatitis B Virus Infection; A Vanishing Disease in Iranian Children

886

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

887

Hepatitis B virus large surface protein: function and fame

888

Hepatitis B virus mutants and efficacy of vaccination

889

Hepatitis B virus mutants and efficacy of vaccination

890

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

891

Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma

892

Hepatitis B Virus PreS Variant and Hepatocellular Carcinoma

893

Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter

894

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

895

Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research

896

Hepatitis B virus replication and viral antigen synthesis in hepatocyte lines derived from normal human liver

897

Hepatitis B virus resistance to antivirals: clinical implications and management

898

Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy

899

Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis

900

Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese

901

Hepatitis B Virus Should not be Forget in Health Care Worker

902

Hepatitis B virus subtypes and lamivudine resistance

903

Hepatitis B Virus Surface Antigen (HBsAg) Mutations Are Rare but Clustered in Immune Epitopes in Chronic Carriers from Sistan-Balouchestan Province, Iran

904

Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran

905

Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma

906

Hepatitis B Virus Vaccination in Hemodialysis Patients: A Necessity for Individualizing of Immunization?

907

Hepatitis B Virus Vaccine immune response in Egyptian children 15-17 years after primary immunization; should we provide a booster dose?

908

Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase

909

Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish

910

Hepatitis B virus X gene is implicated in liver carcinogenesis

911

Hepatitis B virus X mediates podocyte pyroptosis by regulating the ROS/NLRP3 signaling pathway in hepatitis B virus-associated glomerulonephritis

912

Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response

913

Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection

914

Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression

915

Hepatitis B virus X protein interacts with NF-KB inhibitors

916

Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16INK4a expression via DNA methylation

917

Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3

918

Hepatitis B virus X protein stimulates the Hedgehog–Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells

919

Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells

920

Hepatitis B virus YMDD-motif mutations with emergence of lamivudine-resistant mutants: a threat to recovery

921

Hepatitis B Virus, Hepatitis C Virus Markers and Serum Alanine Amino-Transferase (ALT) Levels, in a Young Adult Population of Sylhet District

922

Hepatitis B Virus-associated Glomerulonephritis

923

Hepatitis B Virus-associated Nephropathy An International Data Analysis

924

Hepatitis B viruses and cancerogenesis

925

Hepatitis B viruses: Reverse transcription a different way

926

Hepatitis B virus-induced hepatocellular carcinoma

927

Hepatitis B virus-infected cells can be eliminated by the cytotoxic T cell-mediated immune reaction. Fas ligand, recently detected on the surface of cytotoxic T cell, is thought to induce cells to apoptosis by adhering to Fas antigen. Aims/Methods: To eva

928

Hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy following influenza vaccination

929

Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran

930

Hepatitis B, Hepatitis C and HIV seroprevalence in critically ill emergency medicine department patients in a tertiary inner city hospital in Istanbul, Turkey

931

Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Seropositivity Among Children in Kabul, Afghanistan: A Cross-Sectional Study

932

Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon

933

Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015

934

Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015

935

Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey*

936

Hepatitis B: Epidemiology and prevalence in Iran, during 2002-2014

937

Hepatitis B: Knowledge, Vaccine Situation and Seroconversion of Dentistry Students of a Public University

938

Hepatitis B: Reflections on the current approach to antiviral therapy

939

Hepatitis BMarkers in Isfahan, Central Iran: APopulation-Based Study

940

Hepatitis B-Related Concerns and Anxieties Among People With Chronic Hepatitis B in Australia

941

Hepatitis C (HCV) Viremic Rate and its Correlation to Demographic Factors among HCV Confirmed Iranian Blood Donors

942

Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features

943

Hepatitis C among Hemodialysis Patients: Impact of Strict Adherence to Universal Precautions

944

Hepatitis C among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors

945

HEPATITIS C AMONG YOUNG MALE OFFENDERS ADMITTED TO THE CENTRAL JAIL, LAHORE

946

Hepatitis C and alcohol

947

Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage

948

Hepatitis C and B-cell non-Hodgkin’s lymphoma: a geographicallyvariable association?

949

Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda

950

Hepatitis C and Depression

951

Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran

952

Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran

953

Hepatitis C and Hepatitis B Virus Infection: Epidemiology and Risk Factors in a Large Cohort of Pregnant Women in Lorestan, West of Iran

954

Hepatitis C and HIV infection: biological, clinical, and therapeutic implications

955

Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems

956

Hepatitis C and liver transplantation

957

Hepatitis C and pulmonary fibrosis

958

Hepatitis C and renal failure

959

Hepatitis C and Steatosis

960

Hepatitis C and Teens

961

Hepatitis C and Teens

962

Hepatitis C and the correctional population

963

Hepatitis C and the heart: to beat or not to beat

964

Hepatitis C and thyroid autoimmunity: is there a link?

965

Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013

966

Hepatitis C at work place: A survey of Occupational Health and Safety Knowledge and Practice in Beauty Therapy Industry

967

Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era

968

Hepatitis C detection

969

Hepatitis C detection

970

Hepatitis C genotype and associated risks factors of patients at University Kebangsaan Malaysia Medical Centre

971

Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran

972

Hepatitis C Genotypes in Hemophilia Patients in Iran

973

Hepatitis C Genotypes in Hemophilia Patients in Iran

974

Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma

975

HEPATITIS C IN A COMMUNITY IN UPPER EGYPT: I. CROSS-SECTIONAL SURVEY

976

Hepatitis C in Australia: Impact of a Mass Media Campaign Original Research Article

977

Hepatitis C in haemophilia patients in the Netherlands

978

Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005)

979

Hepatitis C in hemodialysis patients needs more attention for control and review the risk factors

980

Hepatitis C in Iran. How Extensive of a Problem Is It?

981

Hepatitis C in Pakistan: A Review of Available Data

982

HEPATITIS C IN PERU: RISK FACTORS FOR INFECTION, POTENTIAL IATROGENIC TRANSMISSION, AND GENOTYPE DISTRIBUTION

983

Hepatitis C in State Correctional Facilities

984

Hepatitis C in the Eastern Mediterranean Region

985

Hepatitis C in the patient with human immunodeficiency virus infection

986

Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan

987

Hepatitis C infection and autoimmune hemolytic anemia in a patient with colon B-cell non-hodgkin lymphoma: a case report

988

Hepatitis C infection and polymyositis

989

Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis

990

Hepatitis C infection from anti-D immunoglobulin

991

Hepatitis C Infection in Egyptian Psoriatic Patients: Prevalence and Correlation with Severity of Disease

992

Hepatitis C infection in Iran; A review article

993

Hepatitis C Infection in the General Population of Iran: A Systematic Review

994

Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients

995

Hepatitis C infection is characterized by a high incidence of liver cirrhosis, frequently requiring liver transplantation. After orthotopic liver transplantation, recurrence of hepatitis C virus infection is common, but often difficult to differentiate fr

996

Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting

997

Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting

998

Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function

999

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse

1000

Hepatitis C NS3 helicase unwinds RNA in leaps and bounds

بازگشت